Squarepoint
GILD icon

Squarepoint’s Gilead Sciences GILD Stock Holding History

Squarepoint’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.4M Buy
95,900
+43,200
+82% +$6.05M 0.02% 924
2025
Q4 		$6.47M Sell
52,700
-62,500
-54% -$7.6M 0.01% 1300
2025
Q3 		$12.8M Sell
115,200
-242,300
-68% -$27.5M 0.01% 960
2025
Q2 		$39.6M Buy
357,500
+81,800
+30% +$8.71M 0.04% 466
2025
Q1 		$30.9M Buy
275,700
+212,100
+333% +$21.9M 0.04% 502
2024
Q4 		$5.87M Sell
63,600
-48,200
-43% -$4.34M 0.01% 1507
2024
Q3 		$9.37M Buy
111,800
+30,600
+38% +$2.33M 0.01% 1001
2024
Q2 		$5.57M Buy
81,200
+48,100
+145% +$3.21M 0.01% 1299
2024
Q1 		$2.42M Sell
33,100
-300
-0.9% -$23.1K ﹤0.01% 1965
2023
Q4 		$2.71M Buy
33,400
+16,800
+101% +$1.31M 0.01% 1802
2023
Q3 		$1.24M Sell
16,600
-9,000
-35% -$692K ﹤0.01% 2160
2023
Q2 		$1.97M Sell
25,600
-20,400
-44% -$1.63M 0.01% 1664
2023
Q1 		$3.82M Buy
+46,000
New +$3.81M 0.02% 1031
2022
Q2 		– Sell
-73,100
Closed -$4.35M – 3054
2022
Q1 		$4.35M Sell
73,100
-61,500
-46% -$3.93M 0.02% 788
2021
Q4 		$9.77M Buy
134,600
+13,300
+11% +$916K 0.03% 531
2021
Q3 		$8.47M Sell
121,300
-7,400
-6% -$520K 0.02% 564
2021
Q2 		$8.86M Sell
128,700
-97,200
-43% -$6.49M 0.03% 509
2021
Q1 		$14.6M Buy
+225,900
New +$14.6M 0.09% 269

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Squarepoint's GILD Position: Q1 2026 in Review

Squarepoint reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $5.19M and leaving 206,207 shares worth $28.7M. The position accounts for 0.03% of the portfolio, ranked #531.

Squarepoint first reported a position in GILD in Q4 2014 and has held it in 38 quarters since. The position peaked at $129M in Q2 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Squarepoint held 206,207 shares of Gilead Sciences worth $28.7M as of Q1 2026.
  • Squarepoint sold 37,079 Gilead Sciences shares in Q1 2026, an estimated $5.19M.
  • Gilead Sciences made up 0.03% of Squarepoint's portfolio in Q1 2026, its #531 holding.
  • Squarepoint first reported a position in Gilead Sciences in Q4 2014 and has held it in 38 quarters since.
  • Squarepoint's Gilead Sciences position peaked at $129M in Q2 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.